Cellapeutics Bio is developing the popularization of cell therapy with innovative technology.
Based on the “CELLACON® Platform – the technology of somatic cell reprogramming”, the innovation that everyone enjoys, we develop therapy products for degenerative/ intractable diseases that cannot be fundamentally treated.
“CELLACON® Platform – the technology of somatic cell reprogramming” is a technology that converts patient’s somatic cells directly into differentiated cells for treatment and uses them as therapy products based on a small-molecule drug formula, which innovatively makes up for the shortcomings of existing cell therapy products.